Sign in or create an account to add this stock to your watchlist.
About Vasomedical (OTCMKTS:VASO)
Vaso Corporation operates in the healthcare equipment and information technology industries in the United States and internationally. It operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. It offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for large OEMs into the health provider middle market. Its offerings include General Electric Healthcare (GEHC) diagnostic imaging capital equipment, GEHC service agreements, and GEHC and third party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment provides Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for physiological signals, such as ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and enhanced external counterpulsaion therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease, as well as in-service and training support. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was founded in 1987 and is headquartered in Plainview, New York.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:VASO
CUSIPN/A
Phone516-997-4600
Debt
Debt-to-Equity Ratio0.67
Current Ratio0.67
Quick Ratio0.61
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$72.78 million
Price / Sales0.11
Cash FlowN/A
Price / CashN/A
Book Value$0.05 per share
Price / Book0.90
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-4,530,000.00
Net Margins-6.06%
Return on Equity-49.28%
Return on Assets-8.27%
Miscellaneous
Employees308
Outstanding Shares176,630,000
Vasomedical (OTCMKTS:VASO) Frequently Asked Questions
What is Vasomedical's stock symbol?
Vasomedical trades on the OTCMKTS under the ticker symbol "VASO."
When is Vasomedical's next earnings date?
Who are some of Vasomedical's key competitors?
Some companies that are related to Vasomedical include Digirad (DRAD), Dynatronics (DYNT), Nexeon MedSystems (NXNN), Aradigm (ARDM), CHF Solutions (CHFS), EnteroMedics (RSLS), Non-Invasive Monitoring System (NIMU), FC Global Realty (FCRE), Endra (NDRA), Precision Optics (PEYE), Escalon Medical (ESMC), Trimedyne (TMED), SpectraScience (SCIE), 21st North (ULGX) and Guided Therapeutics (GTHP).
Who are Vasomedical's key executives?
Vasomedical's management team includes the folowing people:
- Dr. Jun Ma, Pres, CEO & Director (Age 55)
- Mr. Michael J. Beecher, CFO & Sec. (Age 73)
- Mr. Peter C. Castle, COO & Director (Age 50)
- Mr. Jonathan P. Newton, VP of Fin. & Treasurer (Age 57)
- Mr. Shawl B. Lobree, Pres of VasoHealthcare
Has Vasomedical been receiving favorable news coverage?
News articles about VASO stock have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Vasomedical earned a coverage optimism score of 0.18 on Accern's scale. They also gave press coverage about the company an impact score of 45.49 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.
How do I buy shares of Vasomedical?
Shares of VASO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Vasomedical's stock price today?
One share of VASO stock can currently be purchased for approximately $0.0451.
How big of a company is Vasomedical?
Vasomedical has a market capitalization of $8.81 million and generates $72.78 million in revenue each year. Vasomedical employs 308 workers across the globe.
How can I contact Vasomedical?
Vasomedical's mailing address is 137 COMMERCIAL STREET SUITE 200, PLAINVIEW NY, 11803. The company can be reached via phone at 516-997-4600 or via email at [email protected]
MarketBeat Community Rating for Vasomedical (VASO)
MarketBeat's community ratings are surveys of what our community members think about Vasomedical and other stocks. Vote "Outperform" if you believe VASO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VASO will underperform the S&P 500 over the long term. You may vote once every thirty days.
Vasomedical (OTCMKTS:VASO) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 5/22/2016 forward)
Vasomedical (OTCMKTS:VASO) Earnings History and Estimates Chart
Vasomedical (OTCMKTS VASO) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/13/2018 | | | | | | | | |
| 8/14/2017 | Q2 2017 | | ($0.01) | | $17.85 million | View | N/A |  |
| 5/15/2017 | Q1 2017 | | ($0.01) | | $16.37 million | View | N/A | |
| 3/30/2016 | Q4 2015 | | $0.01 | | $21.38 million | View | N/A | |
| 11/13/2015 | Q3 2015 | | ($0.01) | | $17.40 million | View | N/A | |
| 3/30/2015 | Q4 2014 | | $0.02 | | $12.36 million | View | N/A | |
| 5/14/2014 | Q1 2014 | | ($0.01) | | $7.09 million | View | N/A | |
| 11/20/2012 | Q3 2012 | | ($0.02) | | | View | N/A | |
| 5/15/2012 | Q1 2012 | | ($0.01) | | | View | N/A | |
| 1/17/2012 | Q4 2011 | | $0.01 | | | View | N/A | |
| 10/17/2011 | Q3 2011 | | ($0.01) | | | View | N/A | |
| 8/30/2011 | Q2 2011 | | ($0.01) | | | View | N/A | |
| 1/18/2011 | Q4 2010 | | ($0.01) | | | View | N/A | |
| 10/15/2008 | Q3 2008 | | ($0.01) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Vasomedical (OTCMKTS:VASO) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Vasomedical (OTCMKTS VASO) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 9.19%
Institutional Ownership Percentage: 0.01%
Vasomedical (OTCMKTS VASO) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/5/2017 | Jun Ma | Insider | Buy | 150,000 | $0.06 | $9,000.00 | | |
| 11/17/2016 | Jun Ma | Insider | Buy | 60,000 | $0.12 | $7,200.00 | | |
| 11/15/2016 | Jun Ma | Insider | Buy | 30,000 | $0.13 | $3,900.00 | | |
| 8/16/2016 | Jun Ma | Insider | Buy | 30,000 | $0.14 | $4,200.00 | | |
| 5/17/2016 | Jun Ma | Insider | Buy | 50,000 | $0.16 | $8,000.00 | 3,109,841 | |
| 11/20/2015 | Jun Ma | insider | Buy | 40,000 | $0.19 | $7,600.00 | 3,109,841 | |
| 8/18/2015 | Michael Beecher | CFO | Buy | 20,000 | $0.17 | $3,400.00 | | |
| 8/17/2015 | Jun Ma | Insider | Buy | 50,000 | $0.17 | $8,500.00 | | |
| 6/12/2015 | Michael Beecher | CFO | Buy | 20,400 | $0.18 | $3,672.00 | | |
| 6/9/2015 | Jun Ma | Insider | Buy | 49,007 | $0.17 | $8,331.19 | | |
(Data available from 1/1/2013 forward)
Vasomedical (OTCMKTS VASO) News Headlines
| Source: |
|
Vasomedical (OTCMKTS:VASO) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Vasomedical (OTCMKTS:VASO) Income Statement, Balance Sheet and Cash Flow Statement
Vasomedical (OTCMKTS VASO) Stock Chart for Tuesday, May, 22, 2018
Loading chart…
